Results
|
|
301.
|
A multicentre phase II trial of gemcitabine for the treatment of patients with newly diagnosed, relapsed or chemotherapy resistant mantle cell lymphoma: SAKK 36/03. [electronic resource] by
- Hitz, F
- Martinelli, G
- Zucca, E
- von Moos, R
- Mingrone, W
- Simcock, M
- Peterson, J
- Cogliatti, S B
- Bertoni, F
- Zimmermann, D R
- Ghielmini, M
Producer: 20091013
In:
Hematological oncology vol. 27
Availability: No items available.
|
|
|
302.
|
Human eukaryotic initiation factor EIF2C1 gene: cDNA sequence, genomic organization, localization to chromosomal bands 1p34-p35, and expression. [electronic resource] by
- Koesters, R
- Adams, V
- Betts, D
- Moos, R
- Schmid, M
- Siermann, A
- Hassam, S
- Weitz, S
- Lichter, P
- Heitz, P U
- von Knebel Doeberitz, M
- Briner, J
Producer: 19991209
In:
Genomics vol. 61
Availability: No items available.
|
|
|
303.
|
Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia/cachexia: a randomised, placebo-controlled, double-blind, double-crossover study. [electronic resource] by
- Strasser, F
- Lutz, T A
- Maeder, M T
- Thuerlimann, B
- Bueche, D
- Tschöp, M
- Kaufmann, K
- Holst, B
- Brändle, M
- von Moos, R
- Demmer, R
- Cerny, T
Producer: 20080327
In:
British journal of cancer vol. 98
Availability: No items available.
|
|
|
304.
|
Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings. [electronic resource] by
- Kubicka, S
- Greil, R
- André, T
- Bennouna, J
- Sastre, J
- Van Cutsem, E
- von Moos, R
- Osterlund, P
- Reyes-Rivera, I
- Müller, T
- Makrutzki, M
- Arnold, D
Producer: 20140514
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 24
Availability: No items available.
|
|
|
305.
|
The effect of real-time electronic monitoring of patient-reported symptoms and clinical syndromes in outpatient workflow of medical oncologists: E-MOSAIC, a multicenter cluster-randomized phase III study (SAKK 95/06). [electronic resource] by
- Strasser, F
- Blum, D
- von Moos, R
- Cathomas, R
- Ribi, K
- Aebi, S
- Betticher, D
- Hayoz, S
- Klingbiel, D
- Brauchli, P
- Haefner, M
- Mauri, S
- Kaasa, S
- Koeberle, D
Producer: 20161111
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 27
Availability: No items available.
|
|
|
306.
|
Nilotinib in the treatment of advanced gastrointestinal stromal tumours resistant to both imatinib and sunitinib. [electronic resource] by
- Montemurro, M
- Schöffski, P
- Reichardt, P
- Gelderblom, H
- Schütte, J
- Hartmann, J T
- von Moos, R
- Seddon, B
- Joensuu, H
- Wendtner, C M
- Weber, E
- Grünwald, V
- Roth, A
- Leyvraz, S
Producer: 20090915
In:
European journal of cancer (Oxford, England : 1990) vol. 45
Availability: No items available.
|
|
|
307.
|
Clinical benefit in patients with metastatic bone disease: results of a phase 3 study of denosumab versus zoledronic acid. [electronic resource] by
- Vadhan-Raj, S
- von Moos, R
- Fallowfield, L J
- Patrick, D L
- Goldwasser, F
- Cleeland, C S
- Henry, D H
- Novello, S
- Hungria, V
- Qian, Y
- Feng, A
- Yeh, H
- Chung, K
Producer: 20130619
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 23
Availability: No items available.
|
|
|
308.
|
Phase I trial of the oral smoothened inhibitor sonidegib in combination with paclitaxel in patients with advanced solid tumors. [electronic resource] by
- Stathis, A
- Hess, D
- von Moos, R
- Homicsko, K
- Griguolo, G
- Joerger, M
- Mark, M
- Ackermann, C J
- Allegrini, S
- Catapano, C V
- Xyrafas, A
- Enoiu, M
- Berardi, S
- Gargiulo, P
- Sessa, C
Producer: 20180806
In:
Investigational new drugs vol. 35
Availability: No items available.
|
|
|
309.
|
Adding cetuximab to capecitabine plus oxaliplatin (XELOX) in first-line treatment of metastatic colorectal cancer: a randomized phase II trial of the Swiss Group for Clinical Cancer Research SAKK. [electronic resource] by
- Borner, M
- Koeberle, D
- Von Moos, R
- Saletti, P
- Rauch, D
- Hess, V
- Trojan, A
- Helbling, D
- Pestalozzi, B
- Caspar, C
- Ruhstaller, T
- Roth, A
- Kappeler, A
- Dietrich, D
- Lanz, D
- Mingrone, W
Producer: 20080902
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 19
Availability: No items available.
|
|
|
310.
|
Multicenter phase II trial of preoperative induction chemotherapy followed by chemoradiation with docetaxel and cisplatin for locally advanced esophageal carcinoma (SAKK 75/02). [electronic resource] by
- Ruhstaller, T
- Widmer, L
- Schuller, J C
- Roth, A
- Hess, V
- Mingrone, W
- von Moos, R
- Borner, M
- Pestalozzi, B C
- BalmerMajno, S
- Köberle, D
- Terraciano, L
- Schnider, A
- Bodis, S
- Popescu, R
Producer: 20091109
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 20
Availability: No items available.
|
|
|
311.
|
Circulating microRNA profiling in patients with advanced non-squamous NSCLC receiving bevacizumab/erlotinib followed by platinum-based chemotherapy at progression (SAKK 19/05). [electronic resource] by
- Joerger, M
- Baty, F
- Früh, M
- Droege, C
- Stahel, R A
- Betticher, D C
- von Moos, R
- Ochsenbein, A
- Pless, M
- Gautschi, O
- Rothschild, S
- Brauchli, P
- Klingbiel, D
- Zappa, F
- Brutsche, M
Producer: 20150709
In:
Lung cancer (Amsterdam, Netherlands) vol. 85
Availability: No items available.
|
|
|
312.
|
First-line temozolomide combined with bevacizumab in metastatic melanoma: a multicentre phase II trial (SAKK 50/07). [electronic resource] by
- von Moos, R
- Seifert, B
- Simcock, M
- Goldinger, S M
- Gillessen, S
- Ochsenbein, A
- Michielin, O
- Cathomas, R
- Schläppi, M
- Moch, H
- Schraml, P H
- Mjhic-Probst, D
- Mamot, C
- Schönewolf, N
- Dummer, R
Producer: 20120522
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 23
Availability: No items available.
|
|
|
313.
|
Combination of bevacizumab and 2-weekly pegylated liposomal doxorubicin as first-line therapy for locally recurrent or metastatic breast cancer. A multicenter, single-arm phase II trial (SAKK 24/06). [electronic resource] by
- Rochlitz, C
- Ruhstaller, T
- Lerch, S
- Spirig, C
- Huober, J
- Suter, T
- Bühlmann, M
- Fehr, M
- Schönenberger, A
- von Moos, R
- Winterhalder, R
- Rauch, D
- Müller, A
- Mannhart-Harms, M
- Herrmann, R
- Cliffe, B
- Mayer, M
- Zaman, K
Producer: 20110322
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 22
Availability: No items available.
|
|
|
314.
|
Lurbinectedin as second- or third-line palliative therapy in malignant pleural mesothelioma: an international, multi-centre, single-arm, phase II trial (SAKK 17/16). [electronic resource] by
- Metaxas, Y
- Früh, M
- Eboulet, E I
- Grosso, F
- Pless, M
- Zucali, P A
- Ceresoli, G L
- Mark, M
- Schneider, M
- Maconi, A
- Perrino, M
- Biaggi-Rudolf, C
- Froesch, P
- Schmid, S
- Waibel, C
- Appenzeller, C
- Rauch, D
- von Moos, R
Producer: 20210106
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 31
Availability: No items available.
|
|
|
315.
|
Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06). [electronic resource] by
- Koeberle, D
- Betticher, D C
- von Moos, R
- Dietrich, D
- Brauchli, P
- Baertschi, D
- Matter, K
- Winterhalder, R
- Borner, M
- Anchisi, S
- Moosmann, P
- Kollar, A
- Saletti, P
- Roth, A
- Frueh, M
- Kueng, M
- Popescu, R A
- Schacher, S
- Hess, V
- Herrmann, R
Producer: 20160209
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 26
Availability: No items available.
|
|
|
316.
|
Do all patients with advanced HER2 positive breast cancer need upfront-chemo when receiving trastuzumab? Randomized phase III trial SAKK 22/99. [electronic resource] by
- Pagani, O
- Klingbiel, D
- Ruhstaller, T
- Nolè, F
- Eppenberger, S
- Oehlschlegel, C
- Bernhard, J
- Brauchli, P
- Hess, D
- Mamot, C
- Munzone, E
- Pestalozzi, B
- Rabaglio, M
- Aebi, S
- Ribi, K
- Rochlitz, C
- Rothgiesser, K
- Thürlimann, B
- von Moos, R
- Zaman, K
- Goldhirsch, A
Producer: 20171225
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 28
Availability: No items available.
|
|
|
317.
|
A randomized phase II study evaluating different maintenance schedules of nab-paclitaxel in the first-line treatment of metastatic breast cancer: final results of the IBCSG 42-12/BIG 2-12 SNAP trial. [electronic resource] by
- Gennari, A
- Sun, Z
- Hasler-Strub, U
- Colleoni, M
- Kennedy, M J
- Von Moos, R
- Cortés, J
- Vidal, M J
- Hennessy, B
- Walshe, J
- Parraga, K Amillano
- Ribi, K
- Bernhard, J
- Murillo, S Morales
- Pagani, O
- Barbeaux, A
- Borstnar, S
- Rabaglio-Poretti, M
- Maibach, R
- Regan, M M
- Jerusalem, G
Producer: 20190408
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 29
Availability: No items available.
|
|
|
318.
|
Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the randomized, open-label, phase II ARTE trial. [electronic resource] by
- Wirsching, H-G
- Tabatabai, G
- Roelcke, U
- Hottinger, A F
- Jörger, F
- Schmid, A
- Plasswilm, L
- Schrimpf, D
- Mancao, C
- Capper, D
- Conen, K
- Hundsberger, T
- Caparrotti, F
- von Moos, R
- Riklin, C
- Felsberg, J
- Roth, P
- Jones, D T W
- Pfister, S
- Rushing, E J
- Abrey, L
- Reifenberger, G
- Held, L
- von Deimling, A
- Ochsenbein, A
- Weller, M
Producer: 20191112
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 29
Availability: No items available.
|